Showing results (61-70 of 239) with videos related to
Sort By:
Pageof 24
International Journal of Clinical Pharmacology and Biopharmacy|June 1, 1975
Clomacran in the treatment of schizophrenic patients: a comparison of two assessment methodsJ C Pecknold, T A Ban, H E Lehmann, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1984
Rapid tranquilization: a comparative study of thiothixene and haloperidolS Kelwala, T A Ban, S A Berney, et al.Journal of Clinical Psychopharmacology|December 10, 1999
International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: IV. Therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disordersE H Uhlenhuth, M B Balter, T A Ban, et al.Depression and Anxiety|June 5, 1999
International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: VI. Trends in recommendations for the pharmacotherapy of anxiety disorders, 1992-1997E H Uhlenhuth, M B Balter, T A Ban, et al.Journal of Clinical Psychopharmacology|January 1, 1999
International Study of Expert Judgement on Therapeutic Use of Benzodiazepines and Other Psychotherapeutic Medications: V. Treatment strategies in panic disorder, 1992-1997E H Uhlenhuth, M B Balter, T A Ban, et al.Psychopharmacology Bulletin|January 1, 1995
International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: III. Clinical features affecting experts' therapeutic recommendations in anxiety disordersE H Uhlenhuth, M B Balter, T A Ban, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 6, 2000
Trends in recommendations for the pharmacotherapy of anxiety disorders by an international expert panel, 1992-1997E H Uhlenhuth, M B Balter, T A Ban, et al.The Journal of Clinical Psychiatry|August 1, 1981
Amoxapine: once versus divided daily doses in neurotic and endogenous depressionM Ragheb, W H Wilson, T A Ban, et al.The Journal of International Medical Research|January 1, 1977
Clomipramine (Anafranil) and behaviour therapy in obsessive-compulsive and phobic disordersM M Amin, T A Ban, J C Pecknold, et al.Medical Hypotheses|October 8, 2005
A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiolEthan Russo, Geoffrey W GuyPageof 24